The new $5 million COVID-19 research fund will support a clinical trial to determine if a commonly used drug can safely be used as a treatment for COVID-19,” said Friesen. “The fund will also provide support for local researchers to develop solutions to health-care issues in response to the COVID-19 pandemic.”
“We are pleased to refocus our research efforts on vital clinical trials and potential interventions in the fight against COVID-19,” said Tracey Maconachie, chair, Research Manitoba. “Our world-renowned partners are conducting leading-edge research that could expedite treatments for Manitobans and all Canadians.”
More than $3.5 million will be used to support clinical and applied research including $700,000 for Manitoba’s first COVID-19 clinical trial for a drug to fight this virus, the minister said. The study will test whether or not the drug hydroxychloroquine, used to treat rheumatology issues, can prevent people from contracting COVID-19. The scientific trial will determine if the drug can safely be used as a treatment for COVID-19.